Feature | August 13, 2012

Support Services Critical as Providers Migrate to Hybrid OR, Says Recent KLAS Study

August 13, 2012 — Providers are increasingly focused on using interventional labs in a hybrid operating room (OR) environment, but better support and training are needed to ensure success in this evolution of technology, suggests some of the findings in a recent KLAS study, “Interventional X-ray 2012: A Continuing Evolution.”

The research indicates that providers are specifically looking for vendors' training quality and readiness for hybrid OR suites when selecting interventional X-ray systems. Healthcare providers across the United States expressed their opinions regarding four specific vendors in the market. For the third year in a row, Toshiba earned the top score for overall satisfaction, followed by Phillips, GE and Siemens. Providers highlighted Toshiba's field support, proactive service and account management. However, Toshiba has only two of their participating customers currently using the Infinix-i as a hybrid OR.

Conversely, with 13 customers using their equipment in a hybrid OR, Siemens has the greatest market penetration in this area. Although providers rated Siemens fourth place overall, Kirk Ising, report author and strategic operations director at KLAS, says that may come with the territory. The reason is that hybrid OR requires a much more complex process to set up, and training is difficult to coordinate and execute effectively.

"Currently, providers who are using a hybrid OR are early adopters," Ising said. "And although Siemens has been first to the table with the technology piece, they will need to improve their contracting, training and implementation processes to better meet providers' expectations."

While Phillips scored higher than Siemens overall, they only have two customers using the FD20 in a hybrid OR. When it comes to implementations, Philips customers report that communication is excellent. However, communication seems to fall off post-implementation, which appears to disappoint hands-on managers.

Provider satisfaction with GE's Innova 3100 has steadily improved in the past five years, giving GE third place in this study. Better service and support have helped GE make their customers more satisfied. The Innova 3100 is not being used in any hybrid OR settings because it is a floor-mounted unit. In order to tap the hybrid OR market, GE released the Discovery IGS 730, which is meant for hybrid OR use, but there are not enough live sites to measure it for the 2012 study.

For more information: www.KLASresearch.com

Related Content

Edwards, Sapien 3 transcatheter heart valve, Canada, approval
News | Heart Valve Technology| July 27, 2016
Edwards Lifesciences Corp. announced that Health Canada has approved the Edwards Sapien 3 transcatheter heart valve for...
PCI outcomes, public reporting, high-risk patients, JAMA Cardiology, Beth Israel Deaconess Medical Center study
News | Cath Lab| July 27, 2016
July 27, 2016 — A number of states mandate public reporting of mortality outcomes following certain cardiac procedure
Abbott, Absorb bioresorbable stent, dissolving, UAB, University of Alabama at Birmingham, first in state
News | Stents Bioresorbable| July 26, 2016
On July 20, Massoud Leesar, M.D., of University of Alabama at Birmingham Hospital implanted a patient with Absorb, the...
CMS, Overall Hospital Quality Star Rating, national distribution, quailty of care
News | Business| July 26, 2016
July 25, 2016 — The Centers for Medicare and Medicaid Services (CMS) announced that it expects to launch its new Over
Stryker Sustainability Solutions, Angiodynamics Soft Vu Omni Flush Angiographic Catheters, recall
News | Angiographic Catheter| July 25, 2016
Stryker Sustainability Solutions (formerly Ascent Healthcare Solutions) is recalling Angiodynamics Soft Vu Omni Flush...
Million Hearts Cardiovascular Disease Risk Reduction Model, CMS, reduce heart attacks and strokes, participants
News | Patient Engagement| July 22, 2016
July 22, 2016 — The Centers for Medicare & Medicaid Services (CMS) recently announced 516 awardees in 47 states,
heart failure, after first heart attack, cancer risk, JACC study
News | Cardiac Diagnostics| July 21, 2016
People who develop heart failure after their first heart attack have a greater risk of developing cancer when compared...
Absorb, bioresorbable stent, BVS

The Abbott Absorb stent gained FDA clearance in July 2016. It has metallic markers at each end so it can be visualized for proper positioning under angiographic X-ray imaging. 

Feature | Stents Bioresorbable| July 21, 2016 | Alphonse Ambrosia, D.O.
Some have labeled bioresorbable scaffolds (BRS), also known as bioresorbable stents, as the fourth evolution of inter
Sponsored Content | Videos | Inventory Management| July 19, 2016
You have bigger priorities than managing inventory.
Abbott Absorb bioresorbable stent, dissolving BVS, first West Coast implant, Good Samaritan Hospital Los Angeles
News | Stents Bioresorbable| July 19, 2016
Good Samaritan Hospital, Los Angeles, is the first hospital on the West Coast to offer patients with coronary artery...
Overlay Init